Stanley Research Program at Sheppard Pratt

Program Director: Faith Dickerson, Ph.D.

Phone: 410-938-4359

The Stanley Research Program at Sheppard Pratt conducts studies on schizophrenia and bipolar disorder. The program is funded by the Stanley Medical Research Institute in Bethesda, Maryland, a foundation dedicated to supporting research on the causes and treatments of serious mental illness. The Stanley Research Program at Sheppard Pratt is pursuing several investigations as to the role of infectious agents and inflammatory markers in serious mental illness. The program is also performing a clinical trial of probiotics as an add-on treatment for individuals with mania and a clinical trial of adjunctive valacyclovir to improve cognitive functioning in the early course of schizophrenia.

We are dedicated to advancing knowledge about schizophrenia and bipolar disorder, as well as about treatments that may help in reducing the symptoms of these illnesses. The program is staffed by:

Faith Dickerson, Ph.D., Psychologist and Program Director

Sunil Khushalani, M.D., Psychiatrist

Cassie Stallings, R.N.C., Senior Clinical Research Nurse

Andrea Origoni, Data Manager

Emily Katsafanas, Clinical Research Coordinator

Lucy Schweinfurth, Research Project Coordinator

Christina Savage, Research Project Coordinator

Maria Banis, Assistant Research Project Coordinator

We welcome calls or inquiries from persons who may be interested in the program's work. For further information, please email Cassie Stallings at cstallings@sheppardpratt.org.

For a list of current research opportunities, click here.